We study the journal which talks about the outcomes of isolated neutropenia referred to pediatric hematology-oncology clinic, which published on Pediatrics in Oct.2020. This article is focused on the etiology of neutropenia and the follow-up results. We hope that can help physicians familiar with the topic more and know when should we start further examiantions.
3. Children with isolated neutropenia (absolute neutrophil
count [ANC] <1500/mL)
referred to pediatric hematology and oncology
clinics for further diagnostic evaluation
Citation/ PEDIATRICS Volume 146, number 4, October 2020
4. Benign ethnic neutropenia (BEN)
● Normative neutrophil counts can vary by race.
● Individuals of African descent that have a baseline
ANC<1500/mL
Citation/ PEDIATRICS Volume 146, number 4, October 2020
5. We hypothesized that children will have
resolution of their neutropenia without the need
for intervention(s) by a pediatric hematologist and
oncologist.
Citation/ PEDIATRICS Volume 146, number 4, October 2020
7. Subjects
● From January 2013 through August 2018
● Children who were referred to the University of
Alabama at Birmingham pediatric
hematologyoncology clinic for isolated
neutropenia
● 155 children ages 0 to 18 years
Citation/ PEDIATRICS Volume 146, number 4, October 2020
8. Excluded
● Children referred with neutropenia who were
found to have either anemia and/or
thrombocytopenia
● Children referred for neutropenia who did not
adhere to their referral evaluation
Citation/ PEDIATRICS Volume 146, number 4, October 2020
9. Mild Moderate Severe Very severe
Neutrophil
count (ANC)
1001–
1500/mL
501–
1000/mL
501–
1000/mL
< 200/mL
For the current ANC, we categorized children as resolved if ANC
>1500/mL.
Citation/ PEDIATRICS Volume 146, number 4, October 2020
10. Definition of Variables
● Extracted the date of the first identified episode of
neutropenia and number of CBCs performed
before the referral visit.
● Recorded the date of referral and the referral ANC.
● Identify the lowest ANC and the current ANC.
Neutropenia
Citation/ PEDIATRICS Volume 146, number 4, October 2020
11. We documented the age, sex, race, and
medications at the time of referral for all children.
Definition of Variables
Citation/ PEDIATRICS Volume 146, number 4, October 2020
12. Definition of Variables
Diagnoses and Outcomes
• Drug-induced neutropenia: medications
• Rheumatologic etiology:
-antinuclear antibody testing
-antineutrophil antibody testing
• Congenital or cyclic neutropenia:
-elastase, neutrophil-expressed (ELANE) gene
testing
Citation/ PEDIATRICS Volume 146, number 4, October 2020
13. Definition of Variables
Diagnoses and Outcomes
• Cancer or bone marrow failure disorders:
-bone marrow aspiration and biopsy reports
• Infection-related neutropenia:
-microbiology and virology records
Descriptive statistics
Citation/ PEDIATRICS Volume 146, number 4, October 2020
15. Study Population at Referral
The mean age of children at the time of referral for isolated neutropenia
was 8.1 +- 5.9 years.
Mild
neutropenia
Moderate
neutropenia
Severe
neutropenia
Very
severe neutropenia
45 (29%) 65 (42%) 30 (19%) 15 (10%)
Boys Girls
92 (60%) 63 (40%)
Black white Asian American
87 (56%) 67 (43%) 1 (1%)
Citation/ PEDIATRICS Volume 146, number 4, October 2020
16. Referral Characteristics
• The median time from the first abnormal CBC to the
referral visit was 2 months.
- Severe neutropenia: 1 month
- Moderate neutropenia: 3 months
- Mild neutropenia: 2 months
Citation/ PEDIATRICS Volume 146, number 4, October 2020
18. Diagnostic Testing
• Bone marrow aspiration and biopsy:
- normal 16 / 32
- hypocellular marrow
• No children were found to have a malignancy
Citation/ PEDIATRICS Volume 146, number 4, October 2020
19. Change From Referral ANC Category
to the Lowest ANC Category
Citation/ PEDIATRICS Volume 146, number 4, October 2020
20. Change From Referral ANC Category
to the Lowest ANC Category
Citation/ PEDIATRICS Volume 146, number 4, October 2020
21. Change From Lowest ANC Category
to Their Current ANC Category
Citation/ PEDIATRICS Volume 146, number 4, October 2020
22. Change From Lowest ANC Category
to Their Current ANC Category
Citation/ PEDIATRICS Volume 146, number 4, October 2020
23. Change From Lowest ANC Category
to Their Current ANC Category
Citation/ PEDIATRICS Volume 146, number 4, October 2020
24. Change From Lowest ANC Category
to Their Current ANC Category
Citation/ PEDIATRICS Volume 146, number 4, October 2020
25. Change From Lowest ANC Category
to Their Current ANC Category
Citation/ PEDIATRICS Volume 146, number 4, October 2020
26. Outcomes Based on Referral ANC
Citation/ PEDIATRICS Volume 146, number 4, October 2020
27. Outcomes Based on Referral ANC
Citation/ PEDIATRICS Volume 146, number 4, October 2020
28. Outcomes Based on Referral ANC
Citation/ PEDIATRICS Volume 146, number 4, October 2020
29. Outcomes Based on Referral ANC
Citation/ PEDIATRICS Volume 146, number 4, October 2020
30. Outcomes Based on Referral ANC
Citation/ PEDIATRICS Volume 146, number 4, October 2020
31. Current Diagnosis
• Common medications
responsible for
neutropenia
• AEDs
• Zonisamide
• Oxcarbazepine
• Diazepam
• Lacosamide
• Carbamazepine
• Lamotrigine
• Valproate
• Immunosuppressants
• Azathioprine
• Methotrexate
• Infliximab
• Etanercept
• Mycophenolic acid
• Radioactive iodine
Citation/ PEDIATRICS Volume 146, number 4, October 2020
32. ● 24 children with persistent mild neutropenia of unknown etiology, 20
(83%) of whom were Black.
● Black children had a 3.5 higher odds of having a persistent mild
neutropenia.
Racial Differences in Outcomes
Black Children White Children P
referral ANC 1038 per mm3 907 per mm3 0.11
current ANC 1892 per mm3 2528 per mm3 0.01
resolved
neutropenia
49 (56%) 50 (76%) 0.01
Citation/ PEDIATRICS Volume 146, number 4, October 2020
33. ● 6 children (4%) received G-CSF
○ including 4 of 15 children referred with very severe
neutropenia
● 4 children discontinued offending medication
● 5 children required rheumatology or immunology
management
Interventions
Citation/ PEDIATRICS Volume 146, number 4, October 2020
35. ● 10 children were admitted for a total of 16 admissions
among 155 children referred with isolated neutropenia
Hospitalizations
febrile neutropenia, n = 13, 81%
*others, n = 3, 19%
*cellulitis = 1, rash with neutropenia = 1, alloimmune neutropenia = 1
Citation/ PEDIATRICS Volume 146, number 4, October 2020
37. Discussion
Majority of children referred with isolated neutropenia eventually
resolved without any intervention.
Normal ANC at their initial referral visit: 30%
No diagnosis of malignancy
Low hospital admission rates
No bacteremia was identified
Citation/ PEDIATRICS Volume 146, number 4, October 2020
38. Children with mild neutropenia
children with
mild neutropenia
complete resolution
continued to have
mild neutropenia
(-) Need of intervention
(-) Required hospitalization for febrile neutropenia
Citation/ PEDIATRICS Volume 146, number 4, October 2020
75%
25%
39. No standard of care guidelines exist to determine the
frequency of CBC monitoring in children with neutropenia.
We could not determine how long PCPs should monitor
CBCs before referring a child with persistent mild isolated
neutropenia.
However, we identified a median time of 5 months from
initial CBC to the first identified resolved CBC.
Citation/ PEDIATRICS Volume 146, number 4, October 2020
40. 4% (6 patients)
hospitalization for febrile neutropenia or documented infection
Citation/ PEDIATRICS Volume 146, number 4, October 2020
41. Benign ethnic neutropenia (BEN)
High proportion of Black children
- 27% of the black population in Alabama
- 56% of referral population self-identified as Black
Black children with isolated neutropenia
less likely to have resolution of neutropenia
higher odds of having persistent mild isolated neutropenia
Black children have differences in baseline neutrophil counts.
Although BEN is a diagnosis of exclusion, 83% of children with persistent
isolated mild neutropenia in this cohort were Black, suggesting this diagnosis.
Citation/ PEDIATRICS Volume 146, number 4, October 2020
42. Cause of isolated neutropenia
Etiology is unknown in most cases.
Potential contributors to inability to identify a cause of isolated neutropenia
1. Diagnosed during an evaluation for an acute illness.
possible impression: transient neutropenia associated with an infection
(not confirmed, lack of positive viral testing result)
2. Autoimmune neutropenia may occur without a positive ANA testing.
3. BEN is a diagnosis of exclusion.
Citation/ PEDIATRICS Volume 146, number 4, October 2020
43. Drug-induced neutropenia
Antiepileptic and immunosuppressant medications were the most
commonly implicated drugs associated with drug-induced neutropenia.
Mechanisms of drug-induced neutropenia
immune mediated destruction
dose-dependent granulopoietic inhibition
dose-independent idiosyncratic reaction
Citation/ PEDIATRICS Volume 146, number 4, October 2020
44. Limitations
(1) Only included children with isolated neutropenia that were adherent
to the initial pediatric hematology-oncology clinic visit
isolated mild neutropenia children is not associated with hematologic pathology
(2) Unstandardized follow-up duration between CBCs
affected the time of documented resolution
(3) Recurrence of neutropenia is unknown
Citation/ PEDIATRICS Volume 146, number 4, October 2020
45. Limitations
(4) We did not perform studies of patient reported outcomes
should evaluate the impact of referrals for isolated neutropenia on quality outcome
(5) No pediatric guidelines to ensure a systematic approach to ordering
definitive testing for diagnosis
increasing the prevalence of undiagnosed cases
Citation/ PEDIATRICS Volume 146, number 4, October 2020
47. Conclusions
[ Mild isolated neutropenia ]
did not progress in severity
did not require therapeutic interventions
[ The need of G-CSF ]
Rare for children with moderate or severe neutropenia to receive G-CSF
Citation/ PEDIATRICS Volume 146, number 4, October 2020
48. Conclusions
[ Hospital admission ]
Required hospital admission: <10%
[ Malignancy ]
No leukemia or any other malignancy
Citation/ PEDIATRICS Volume 146, number 4, October 2020
49. Conclusions
[ Diagnostic ability ]
Majority: not receive a definitive diagnosis
[ Overall ]
This study provides reassuring data for pediatricians.
May ultimately impact referral rates to a pediatric hematologist-oncolog
genetics of BEN
laboratory techniques
Citation/ PEDIATRICS Volume 146, number 4, October 2020
50. CREDITS: This presentation template was created by
Slidesgo, including icons by Flaticon, and infographics
& images by Freepik.
Thanks
Please keep this slide for attribution
Presenter/ R2 曾子政 R1 陳沛妘 PGY 黃郁婷
Supervisor/ VS 王建得 CR 施銘洋
Editor's Notes
Despite concerns that prolonged neutropenia can be associated with an increased risk of acute illness or bacteremia, hospital admission rates were low, and no bacteremia was identified.
However, this was not confirmed because either no virus was identified at the time of the referral visit or the pediatric hematologist-oncologist did not obtain extensive viral testing.
We expect that several children with isolated mild neutropenia that were nonadherent to their referral clinic visits either remained stable or resolved, thus not warranting a second referral. This limitation would likely strengthen our findings that isolated mild neutropenia children is not associated with hematologic pathology.
strengthen our findings that isolated mild neutropenia children is not associated with hematologic pathology
The time of documented resolution reflects the timing of laboratory evaluations rather than the exact day neutropenia resolved.
After resolution of neutropenia, we did not recommend serial monitoring for recurrence of neutropenia. Therefore, children with documented resolved isolated neutropenia may have developed recurrent neutropenia, and, if asymptomatic, the PCP may not have repeated a CBC. Additionally, we cannot confirm whether children with initial resolved neutropenia had recurrence and perhaps were referred to a different institution.
we did not perform studies of patient reported outcomes, which could enhance this research; future research should evaluate the impact of referrals for isolated neutropenia on quality outcome.
additional research into the genetics of BEN and improved sensitivity of laboratory techniques for viral and autoimmune neutropenia could enhance our diagnostic ability.